DAVIS A BRIAN 4
4 · Strongbridge Biopharma plc · Filed Feb 22, 2019
Insider Transaction Report
Form 4
DAVIS A BRIAN
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2019-02-20+20,000→ 33,366 total - Award
Employee Stock Option (right to buy)
2019-02-20+108,500→ 108,500 totalExercise: $4.67Exp: 2029-02-20→ Common Stock (108,500 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest in full on February 20, 2021, provided the Reporting Person is employed by the Issuer on such date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests in sixteen equal quarterly installments beginning May 20, 2019, provided the Reporting Person is employed by the Issuer on each vesting date.